Outcome of urinary tract infection caused by Extended Spectrum Beta-Lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in  Dr Zainoel Abidin General Hospital Aceh

Zinatul Hayati; Kurnia F. Jamil; Afrianda Azhari; Wilda Mahdani; Teuku Fadrial Karmil; Asyriva Yossadania; Dahril Dahril; Yopie Afriandi Habibie

doi:10.15562/bmj.v10i2.2385

Outcome of urinary tract infection caused by Extended Spectrum Beta-Lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in Dr Zainoel Abidin General Hospital Aceh

Zinatul Hayati ,

Kurnia F. Jamil ,

Afrianda Azhari ,

Wilda Mahdani ,

Teuku Fadrial Karmil ,

Asyriva Yossadania ,

Dahril Dahril ,

Yopie Afriandi Habibie ,

PDF |
DOI: https://doi.org/10.15562/bmj.v10i2.2385 |
Published: 2021-06-30

Abstract

Introduction : Extended-spectrum ?-lactamase (ESBL) is a mutated ?-lactamase enzyme that can hydrolyze beta-lactam antibiotics. The aim of this study was to determine the incidence rate, characteristics of patients, antibiotic use and outcome of urinary tract infections (UTIs) due to ESBL-producing Escherichia coli and Klebsiella pneumoniae at Dr Zainoel Abidin General Hospital Aceh.

Method : The samples of this study were all Escherichia coli and Klebsiella pneumoniae isolated from urine culture of UTI cases. Patient characteristics and antibiotic use data were extracted from medical records. UTIs outcome was assessed as clinical improvement or death within a maximum of 30 days of treatment.

Result : The results of this study obtained 63 patients with UTIs caused by E. coli and K. pneumonia of which 52.4% of them were ESBL producers. The incidence of UTIs due to E. coli was higher than that of K. pneumoniae, 63.5% and 36.5% respectively. E. coli ESBL producers were more in number than non-ESBL, conversely K. pneumoniae were mostly non-ESBL. The characteristics of patients with UTIs caused by E. coli and K. pneumoniae were predominant women 52.4%, and most cases were at 56-64 years old. Antibiotic therapy that given before and after culture results to UTI patients were generally ceftriaxone. UTIs outcome due to ESBL producing Escherichia coli and Klebsiella pneumoniae showed that 26/33 (78.8%) patients experienced improvement, however, 7/33 (21.2%) patients died.

Conclusion : The irrational use of ceftriaxone in patients with UTI caused by ESBL producing E. coli and K. pneumoniae has led to a poor outcome for the patient.

References

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269â€“84.
Endriani R, Andrini F, Alfina D. Pola Resistensi Bakteri Penyebab Infeksi Saluran Kemih (ISK) Terhadap Antibakteri di Pekanbaru. J Natur Indones. 2010;12(2):130â€“5.
Sutandhio S, Alisardjono L, Lusida MI. Distribusi dan Pola Kepekaan Enterobacteriaceae dari Spesimen Urin di RSUD Dr Soetomo Surabaya Periode Januari - Juni 2015. Widya Med. 2015;3(1):2â€“9.
Cockerill FR. Performance Standards for Antimicrobial Susceptibility Testing. 21st ed. Vol. 31, Twenty-first Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.
Warganegara E, Apriliana E. The Determining type of Extended Spectrum Î’eta Lactamase Enzyme (ESBL) from Escherichia coli resistance Cephalosporine of third Generation in RSUD Abdoel Moeloek Bandar Lampung. J Kedokt Univ Lampung. 2014;4(7):87â€“96.
Kuntaman K, Hadi U, Paraton H, Qibtiyah M, Wasito E, Koendhori E, et al. Survailan multi senter Klebsiella pneumoniae and Escherichia colipenghasil ESBL di Indonesia. Maj Kedokt Indones. 2013;
Hayati Z, Rizal S, Putri R. Isolation of Extended-Spectrum B-lactamase (ESBL) Producing Escherichia coli and Klebsiella pneumoniae from Clinical Isolates in RSUD dr . Zainoel Abidin , Aceh. Int J Trop Vet Biomed Res. 2019;4(5):16â€“22.
Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P, et al. Gender and Age-Dependent Etiology of Community-Acquired Urinary Tract Infections. Sci World J. 2012;
Saharman YR, Lestari DC. Phenotype Characterization of Beta-Lactamase Producing Enterobacteriaceae in the Intensive Care Unit (ICU) of Cipto Mangunkusumo Hospital in 2011. Indones J Intern Med. 2013;45:11â€“6.
Sumolang SAC, Porotuo J, Soeliongan S. Pola Bakteri pada Penderita Infeksi Saluran Kemih di RSUP Prof. dr. R.D. Kandou Manado. J e-Biomedik. 2013;1(1):597â€“601.
Febrianto AW, Mukaddas A, Faustine I. Rasionalitas Penggunaan Antibiotik pada Pasien Infeksi Saluran Kemih (ISK) di Instalasi Rawat Inap RSUD Undata Palu Tahun 2012. Online J Nat Sci. 2013;2(3):20â€“9.
Lee JBL, Neild GH. Urinary Tract Infection. Medicine (Baltimore). 2007;35(8):423â€“8.
Mantu FN, Goenawi LR, Bodhi W. Evaluasi Penggunaan Antibiotik pada Pasien Infeksi Saluran Kemih di Instalasi Rawat Inap RSUP. Prof. DR. R. D. Kandou Manado Periode Juli 2013 - Juni 2014. Pharmacon J Ilm Farm. 2015;4(4):196â€“202.
Rachman NO, Prenggono MD, Budiarti LY. Uji Sensitivitas Bakteri Penyebab Infeksi Saluran Kemih pada Pasien Diabetes Melitus terhadap Seftriakson Levofloksasin dan Gentamisin. Berk Kedokt. 2016;12(2):205â€“13.
Kumala S, Raisa N, Rahayu L, Kiranasari A. Uji Kepekaan Bakteri yang Diisolasi dari Urin Penderita Infeksi Saluran Kemih (ISK) terhadap Beberapa Antibiotik pada Periode Maret-Juni 2008. Maj Ilmu Kefarmasian. 2009;VI(2):45â€“55.
Cockerill FR. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. 23rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
Utami ER. Antibiotik Resistensi dan Rasionalitas Terapi. El-Hayah. 2011;1(4):191â€“8.